TrustFinance is trustworthy and accurate information you can rely on. If you are looking for financial business information, this is the place for you. All-in-One source for financial business information. Our priority is our reliability.

TrustFinance Global Insights
Thg 05 07, 2026
2 min read
13

Amazon Pharmacy has announced it will stock Novo Nordisk's Ozempic pill for type 2 diabetes and offer same-day delivery. This move significantly expands Amazon's footprint in the competitive GLP-1 drug market, which includes treatments for diabetes and weight loss.
The company already provides Novo Nordisk's weight-loss drug Wegovy and a rival drug from Eli Lilly. The new service will provide same-day Ozempic delivery to approximately 3,000 U.S. locations, with plans to reach 4,500 by the end of the year. This initiative leverages Amazon's extensive logistics network to disrupt the healthcare sector.
This expansion positions Amazon as a formidable competitor to traditional pharmacy chains. With pricing set at $149 monthly for cash payments or as low as $25 with insurance, Amazon aims to attract a broad customer base. The move is expected to pressure existing pharmaceutical distribution channels and influence drug pricing strategies across the industry.
Amazon's push into dispensing popular GLP-1 medications signals a deeper integration into the U.S. healthcare system. Market analysts will closely watch the impact on traditional pharmacy revenues and how competitors adapt to Amazon's logistical and pricing advantages.
Q: What is the price of Ozempic on Amazon Pharmacy?
A: The price is $149 per month for cash customers or can be as low as $25 with insurance coverage.
Q: Is same-day delivery for Ozempic widely available?
A: It is initially available in about 3,000 U.S. locales, with a planned expansion to 4,500 locations by year-end.
Source: Investing.com

TrustFinance Global Insights
AI-assisted editorial team by TrustFinance curating reliable financial and economic news from verified global sources.
Related Articles

08 Thg 05 2026
Trump Scales Back CEO Group for Beijing Summit

08 Thg 05 2026
Macquarie Shares Hit Record High on Surging Profit

08 Thg 05 2026
Anthropic Eyes Near $1T Valuation in $50B Funding Round

08 Thg 05 2026
Sony Projects Profit Rise Despite PS5 Sales Dip

08 Thg 05 2026
Former China Eastern Chairman Faces Bribery Indictment

08 Thg 05 2026
Asian Stocks Dip on Renewed US-Iran Military Tensions

08 Thg 05 2026
Morgan Stanley Taps Top Greater China Tech Stocks

08 Thg 05 2026
Federal Court Rules Trump's 10% Import Tariff Illegal